Ophthalmology, ISSN 0161-6420, 11/2015, Volume 122, Issue 11, pp. 2351 - 2359
Purpose To evaluate the 2-year outcomes of uveitic macular edema. Design Longitudinal follow-up of a randomized cohort. Participants At baseline, 148 eyes of...
PARS PLANITIS | VISUAL-ACUITY | OCULAR COMPLICATIONS | POSTERIOR | OPTICAL COHERENCE TOMOGRAPHY | FLUOCINOLONE ACETONIDE IMPLANT | OPHTHALMOLOGY | INTERMEDIATE | CLINICAL-FEATURES | PANUVEITIS | IMPAIRMENT | Uveitis - diagnosis | Fluocinolone Acetonide - administration & dosage | Glucocorticoids - administration & dosage | Prednisolone - administration & dosage | Prospective Studies | Follow-Up Studies | Intravitreal Injections | Administration, Oral | Tomography, Optical Coherence | Uveitis - drug therapy | Humans | Middle Aged | Drug Implants | Male | Treatment Outcome | Macular Edema - etiology | Visual Acuity - drug effects | Macular Edema - diagnosis | Macular Edema - drug therapy | Adult | Female | Aged | Uveitis - complications | Fluorescein Angiography | Clinical trials | Dropsy | Edema | Care and treatment | Uveitis
PARS PLANITIS | VISUAL-ACUITY | OCULAR COMPLICATIONS | POSTERIOR | OPTICAL COHERENCE TOMOGRAPHY | FLUOCINOLONE ACETONIDE IMPLANT | OPHTHALMOLOGY | INTERMEDIATE | CLINICAL-FEATURES | PANUVEITIS | IMPAIRMENT | Uveitis - diagnosis | Fluocinolone Acetonide - administration & dosage | Glucocorticoids - administration & dosage | Prednisolone - administration & dosage | Prospective Studies | Follow-Up Studies | Intravitreal Injections | Administration, Oral | Tomography, Optical Coherence | Uveitis - drug therapy | Humans | Middle Aged | Drug Implants | Male | Treatment Outcome | Macular Edema - etiology | Visual Acuity - drug effects | Macular Edema - diagnosis | Macular Edema - drug therapy | Adult | Female | Aged | Uveitis - complications | Fluorescein Angiography | Clinical trials | Dropsy | Edema | Care and treatment | Uveitis
Journal Article
Graefe's Archive for Clinical and Experimental Ophthalmology, ISSN 0721-832X, 12/2016, Volume 254, Issue 12, pp. 2479 - 2480
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s00417-016-3459-y
Medicine & Public Health | Ophthalmology | OPHTHALMOLOGY | MACULAR EDEMA SECONDARY | Dexamethasone | Glucocorticoids | Intravitreal Injections | Humans | Drug Implants | Macular Edema | Retinal Vein Occlusion | Visual Acuity | Usage | Steroids
Medicine & Public Health | Ophthalmology | OPHTHALMOLOGY | MACULAR EDEMA SECONDARY | Dexamethasone | Glucocorticoids | Intravitreal Injections | Humans | Drug Implants | Macular Edema | Retinal Vein Occlusion | Visual Acuity | Usage | Steroids
Journal Article
The American Journal of Sports Medicine, ISSN 0363-5465, 3/2013, Volume 41, Issue 3, pp. 625 - 635
Background: Lateral epicondylitis (LE) is a common musculoskeletal disorder for which an effective treatment strategy remains unknown. Purpose: To examine...
injection therapy | glucocorticoid | pain | growth factors | ultrasonography | lateral humeral epicondylitis | platelet-rich plasma | randomized controlled trial | tendinopathy | SPORT SCIENCES | BASE-LINE | CLINICAL-TRIAL | CORTICOSTEROID INJECTION | SPORTS-MEDICINE | FOLLOW-UP | CHRONIC TENNIS ELBOW | MEDIAL EPICONDYLITIS | UPPER-LIMB DISORDERS | TENDON REPAIR | POWER DOPPLER ULTRASOUND | ORTHOPEDICS | Disability Evaluation | Glucocorticoids - therapeutic use | Ultrasonography, Doppler, Color | Double-Blind Method | Humans | Middle Aged | Male | Tennis Elbow - diagnostic imaging | Tennis Elbow - therapy | Tendons - diagnostic imaging | Injections, Intra-Articular | Female | Platelet-Rich Plasma | Pain Measurement | Triamcinolone - therapeutic use | Care and treatment | Usage | Corticosteroids | Platelet-rich plasma | Injections, Saline | Health aspects | Tennis elbow
injection therapy | glucocorticoid | pain | growth factors | ultrasonography | lateral humeral epicondylitis | platelet-rich plasma | randomized controlled trial | tendinopathy | SPORT SCIENCES | BASE-LINE | CLINICAL-TRIAL | CORTICOSTEROID INJECTION | SPORTS-MEDICINE | FOLLOW-UP | CHRONIC TENNIS ELBOW | MEDIAL EPICONDYLITIS | UPPER-LIMB DISORDERS | TENDON REPAIR | POWER DOPPLER ULTRASOUND | ORTHOPEDICS | Disability Evaluation | Glucocorticoids - therapeutic use | Ultrasonography, Doppler, Color | Double-Blind Method | Humans | Middle Aged | Male | Tennis Elbow - diagnostic imaging | Tennis Elbow - therapy | Tendons - diagnostic imaging | Injections, Intra-Articular | Female | Platelet-Rich Plasma | Pain Measurement | Triamcinolone - therapeutic use | Care and treatment | Usage | Corticosteroids | Platelet-rich plasma | Injections, Saline | Health aspects | Tennis elbow
Journal Article
Neuropharmacology, ISSN 0028-3908, 2012, Volume 62, Issue 2, pp. 617 - 627
A large proportion of humans will experience a traumatic event at least once in their lifetime, with up to 10% then going on to developing posttraumatic stress...
PTSD | Prevention | Treatment | Consolidation | Extinction | Review | Glutamate | Glucocorticoid | Fear conditioning | POSTTRAUMATIC-STRESS-DISORDER | D-CYCLOSERINE | RANDOMIZED CONTROLLED-TRIAL | COMBAT-RELATED PTSD | SINGLE-PROLONGED STRESS | ANXIETY-LIKE BEHAVIOR | ADRENAL AXIS ACTIVITY | NEUROSCIENCES | GLUCOCORTICOID-RECEPTOR ACTIVATION | FEAR MEMORY RECONSOLIDATION | CORTICOTROPIN-RELEASING-FACTOR | PHARMACOLOGY & PHARMACY | Antidepressive Agents - therapeutic use | Receptors, Glucocorticoid - antagonists & inhibitors | Antipsychotic Agents - therapeutic use | Extinction, Psychological | Stress Disorders, Post-Traumatic - drug therapy | Humans | Serotonin Uptake Inhibitors - therapeutic use | Fear - psychology | Stress Disorders, Post-Traumatic - psychology | Corticotropin releasing hormone | Corticosteroids | Smart drugs and nutrients | Post-traumatic stress disorder | Glycine | Drug therapy | Health aspects | Medicine, Preventive | Preventive health services | Glucocorticoids | Memory | Cognitive ability | Glutamic acid receptors | Glucocorticoid receptors | Corticotropin-releasing hormone | Neuromodulation | Trauma | Stress | Allosteric properties | Glycine transporter | Norepinephrine | Literature Review | Drug Therapy
PTSD | Prevention | Treatment | Consolidation | Extinction | Review | Glutamate | Glucocorticoid | Fear conditioning | POSTTRAUMATIC-STRESS-DISORDER | D-CYCLOSERINE | RANDOMIZED CONTROLLED-TRIAL | COMBAT-RELATED PTSD | SINGLE-PROLONGED STRESS | ANXIETY-LIKE BEHAVIOR | ADRENAL AXIS ACTIVITY | NEUROSCIENCES | GLUCOCORTICOID-RECEPTOR ACTIVATION | FEAR MEMORY RECONSOLIDATION | CORTICOTROPIN-RELEASING-FACTOR | PHARMACOLOGY & PHARMACY | Antidepressive Agents - therapeutic use | Receptors, Glucocorticoid - antagonists & inhibitors | Antipsychotic Agents - therapeutic use | Extinction, Psychological | Stress Disorders, Post-Traumatic - drug therapy | Humans | Serotonin Uptake Inhibitors - therapeutic use | Fear - psychology | Stress Disorders, Post-Traumatic - psychology | Corticotropin releasing hormone | Corticosteroids | Smart drugs and nutrients | Post-traumatic stress disorder | Glycine | Drug therapy | Health aspects | Medicine, Preventive | Preventive health services | Glucocorticoids | Memory | Cognitive ability | Glutamic acid receptors | Glucocorticoid receptors | Corticotropin-releasing hormone | Neuromodulation | Trauma | Stress | Allosteric properties | Glycine transporter | Norepinephrine | Literature Review | Drug Therapy
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 09/2011, Volume 365, Issue 12, pp. 1088 - 1098
In this trial, patients with poorly controlled asthma despite inhaled glucocorticoid therapy were treated with lebrikizumab, an anti–IL-13 monoclonal antibody....
CELLS | MEDICINE, GENERAL & INTERNAL | DISEASES | INFLAMMATION | VALIDATION | PHENOTYPES | IL-13 | QUESTIONNAIRE | PERIOSTIN | CLUSTER-ANALYSIS | INSIGHTS | Bronchodilator Agents - therapeutic use | Cell Adhesion Molecules - blood | Glucocorticoids - therapeutic use | Asthma - physiopathology | Double-Blind Method | Forced Expiratory Volume - drug effects | Interleukin-13 - antagonists & inhibitors | Antibodies, Monoclonal - pharmacology | Humans | Antibodies, Monoclonal - adverse effects | Interleukin-13 - immunology | Antibodies, Monoclonal - therapeutic use | Male | Asthma - drug therapy | Asthma - immunology | Adult | Female | Drug Therapy, Combination | Care and treatment | Usage | Causes of | Monoclonal antibodies | Genetic aspects | Health aspects | Asthma | Fees & charges | Phenotypes | Statistical analysis | Glucocorticoids | Cytokines | Stock options | Clinical trials | Immunoglobulin E | Lymphocytes T | Interleukin 13 | Medical diagnosis | Patients | Manuscripts | Inventors | Product development | Drug dosages
CELLS | MEDICINE, GENERAL & INTERNAL | DISEASES | INFLAMMATION | VALIDATION | PHENOTYPES | IL-13 | QUESTIONNAIRE | PERIOSTIN | CLUSTER-ANALYSIS | INSIGHTS | Bronchodilator Agents - therapeutic use | Cell Adhesion Molecules - blood | Glucocorticoids - therapeutic use | Asthma - physiopathology | Double-Blind Method | Forced Expiratory Volume - drug effects | Interleukin-13 - antagonists & inhibitors | Antibodies, Monoclonal - pharmacology | Humans | Antibodies, Monoclonal - adverse effects | Interleukin-13 - immunology | Antibodies, Monoclonal - therapeutic use | Male | Asthma - drug therapy | Asthma - immunology | Adult | Female | Drug Therapy, Combination | Care and treatment | Usage | Causes of | Monoclonal antibodies | Genetic aspects | Health aspects | Asthma | Fees & charges | Phenotypes | Statistical analysis | Glucocorticoids | Cytokines | Stock options | Clinical trials | Immunoglobulin E | Lymphocytes T | Interleukin 13 | Medical diagnosis | Patients | Manuscripts | Inventors | Product development | Drug dosages
Journal Article
Endocrine Reviews, ISSN 0163-769X, 08/2015, Volume 36, Issue 4, pp. 385 - 486
Cushing's disease (CD), or pituitary-dependent Cushing's syndrome, is a severe endocrine disease caused by a corticotroph pituitary tumor and associated with...
GAMMA-KNIFE RADIOSURGERY | CORTICOTROPIN-RELEASING HORMONE | PLASMA ACTH LEVELS | TRANSSPHENOIDAL PITUITARY SURGERY | STEROID-BIOSYNTHESIS INHIBITORS | BILATERAL LAPAROSCOPIC ADRENALECTOMY | SOMATOSTATIN ANALOG SMS-201-995 | ENDOCRINOLOGY & METABOLISM | LONG-TERM REMISSION | QUALITY-OF-LIFE | GLUCOCORTICOID-RECEPTOR ANTAGONIST | Pituitary Neoplasms - surgery | Reoperation | Cardiovascular Diseases | Receptors, Glucocorticoid - antagonists & inhibitors | Pituitary Gland - surgery | Humans | Hydrocortisone - urine | Combined Modality Therapy | Adrenal Glands - surgery | Pituitary ACTH Hypersecretion - drug therapy | Morbidity | Infection | Mental Disorders | Metabolic Syndrome | Pituitary ACTH Hypersecretion - mortality | Pituitary Neoplasms - radiotherapy | Adrenal Glands - drug effects | Hydrocortisone - blood | Pituitary ACTH Hypersecretion - therapy | Adrenocorticotropic Hormone - blood | Pituitary Gland - drug effects | Reviews
GAMMA-KNIFE RADIOSURGERY | CORTICOTROPIN-RELEASING HORMONE | PLASMA ACTH LEVELS | TRANSSPHENOIDAL PITUITARY SURGERY | STEROID-BIOSYNTHESIS INHIBITORS | BILATERAL LAPAROSCOPIC ADRENALECTOMY | SOMATOSTATIN ANALOG SMS-201-995 | ENDOCRINOLOGY & METABOLISM | LONG-TERM REMISSION | QUALITY-OF-LIFE | GLUCOCORTICOID-RECEPTOR ANTAGONIST | Pituitary Neoplasms - surgery | Reoperation | Cardiovascular Diseases | Receptors, Glucocorticoid - antagonists & inhibitors | Pituitary Gland - surgery | Humans | Hydrocortisone - urine | Combined Modality Therapy | Adrenal Glands - surgery | Pituitary ACTH Hypersecretion - drug therapy | Morbidity | Infection | Mental Disorders | Metabolic Syndrome | Pituitary ACTH Hypersecretion - mortality | Pituitary Neoplasms - radiotherapy | Adrenal Glands - drug effects | Hydrocortisone - blood | Pituitary ACTH Hypersecretion - therapy | Adrenocorticotropic Hormone - blood | Pituitary Gland - drug effects | Reviews
Journal Article
Journal of the European Academy of Dermatology and Venereology, ISSN 0926-9959, 05/2018, Volume 32, Issue 5, pp. 657 - 682
This guideline was developed as a joint interdisciplinary European project, including physicians from all relevant disciplines as well as patients. It is a...
0.1-PERCENT TACROLIMUS OINTMENT | LONG-TERM MANAGEMENT | EAACI FOOD ALLERGY | PHOSPHODIESTERASE-4 PDE4 INHIBITOR | PIMECROLIMUS CREAM 1-PERCENT | DOUBLE-BLIND | BAND UVB PHOTOTHERAPY | STAPHYLOCOCCUS-AUREUS COLONIZATION | TOPICAL CALCINEURIN INHIBITORS | PATCH TEST APT | DERMATOLOGY | Allergens - adverse effects | Environmental Pollutants - adverse effects | Emollients - therapeutic use | Glucocorticoids - administration & dosage | Glucocorticoids - therapeutic use | Humans | Skin Care | Child, Preschool | Infant | Administration, Cutaneous | Dermatitis, Atopic - therapy | Dermatitis, Atopic - etiology | Pruritus - therapy | Adult | Pruritus - etiology | Child | Infant, Newborn | Severity of Illness Index | Europe | Environmental Exposure - prevention & control | Consensus | Phototherapy | Food Hypersensitivity - complications | Diet | Calcineurin Inhibitors - therapeutic use | Adolescent | Food Hypersensitivity - diagnosis | Atopic dermatitis | Dermatology | Immunotherapy | Alternative medicine | Formulae, receipts, prescriptions | Practice guidelines (Medicine) | Dermatologic agents | Drug therapy
0.1-PERCENT TACROLIMUS OINTMENT | LONG-TERM MANAGEMENT | EAACI FOOD ALLERGY | PHOSPHODIESTERASE-4 PDE4 INHIBITOR | PIMECROLIMUS CREAM 1-PERCENT | DOUBLE-BLIND | BAND UVB PHOTOTHERAPY | STAPHYLOCOCCUS-AUREUS COLONIZATION | TOPICAL CALCINEURIN INHIBITORS | PATCH TEST APT | DERMATOLOGY | Allergens - adverse effects | Environmental Pollutants - adverse effects | Emollients - therapeutic use | Glucocorticoids - administration & dosage | Glucocorticoids - therapeutic use | Humans | Skin Care | Child, Preschool | Infant | Administration, Cutaneous | Dermatitis, Atopic - therapy | Dermatitis, Atopic - etiology | Pruritus - therapy | Adult | Pruritus - etiology | Child | Infant, Newborn | Severity of Illness Index | Europe | Environmental Exposure - prevention & control | Consensus | Phototherapy | Food Hypersensitivity - complications | Diet | Calcineurin Inhibitors - therapeutic use | Adolescent | Food Hypersensitivity - diagnosis | Atopic dermatitis | Dermatology | Immunotherapy | Alternative medicine | Formulae, receipts, prescriptions | Practice guidelines (Medicine) | Dermatologic agents | Drug therapy
Journal Article